ZYUS Life Sciences Corporation (ZYUS:TSXV) closed at $0.370 on November 20, 2026, down 7.50% on the day. The stock trades 50.7% below its 52-week high of $0.750 and 23.3% above its 52-week low of $0.300. Over the past year, it lost 38.3%. ZYUS Life Sciences Corporation is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, ZYUS closed higher on 29 days (12%). Its best day was September 15, 2026 (+66.67%) and its worst was October 26, 2026 (-30.00%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 10 times.
ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and innovative exempt market therapeutics. Through clinical research, ZYUS is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product candidates and intellectual property activities to protect its novel formulations. Additionally, ZYUS is dedicated to delivering high quality, cGMP / EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The ZYUS vision is to elevate cannabinoid-based therapeutics as a standard of care and expand the potential of protein-based formulations in pursuit of a transformational impact on patients' lives around the world.
Find more stocks like ZYUS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.